Akoya Biosciences Inc logo

AKYA - Akoya Biosciences Inc Share Price

$17.89 -1.2  -6.5%

Last Trade - 11/05/21

Mid Cap
Market Cap £496.9m
Enterprise Value £521.7m
Revenue £30.1m
Position in Universe 3194th / 6853
Unlock AKYA Revenue
Relative Strength (%)
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -33.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 42.2 42.4 +0.5%
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, AkoyaBiosciences Inc revenues increased less than 1% to $42.4M.Net loss applicable to common stockholders increased 19% to$21.8M. Revenues reflect Service and other revenue segmentincrease of 53% to $9M, Consumables segment increase of 5%to $8.5M, EMEA segment increase of 12% to $11.9M, APACsegment increase of 10% to $10.4M, also reflect Instrumentssegment decrease of 10% to $23.8M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


AKYA Revenue Unlock AKYA Revenue

Net Income

AKYA Net Income Unlock AKYA Revenue

Normalised EPS

AKYA Normalised EPS Unlock AKYA Revenue

PE Ratio Range

AKYA PE Ratio Range Unlock AKYA Revenue

Dividend Yield Range

AKYA Dividend Yield Range Unlock AKYA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
AKYA EPS Forecasts Unlock AKYA Revenue
Profile Summary

Akoya Biosciences, Inc. is a life sciences technology company. The Company provides spatial biology solutions. Through its Co-Detection by indEXing (CODEX) and Phenoptics platforms, reagents, software and services, it offers end-to-end solutions to perform tissue analysis and spatial phenotyping across the continuum, from discovery through translational and clinical research. CODEX is a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition. It provides a comprehensive spatial biology solution, converting its customer’s standard fluorescent microscope into an automated imaging system to produce ultra-high parameter multiplex images capable of providing in situ analysis at the cellular and subcellular scales. Its Phenoptics platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or FFPE tissue sections and tissue microarrays (TMAs) utilizing an automated and high-throughput workflow.

Last Annual December 31st, 2020
Last Interim January 1st, 1970
Incorporated November 13, 2015
Public Since April 16, 2021
No. of Shareholders: n/a
No. of Employees: 169
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 36,676,344
Free Float (0.0%)
Eligible for
AKYA Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for AKYA
Upcoming Events for AKYA
Frequently Asked Questions for Akoya Biosciences Inc
What is the Akoya Biosciences Inc share price?

As of 11/05/21, shares in Akoya Biosciences Inc are trading at $17.89, giving the company a market capitalisation of £496.9m. This share price information is delayed by 15 minutes.

How has the Akoya Biosciences Inc share price performed this year?

Shares in Akoya Biosciences Inc are currently trading at $17.89 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Akoya Biosciences Inc price has moved by % over the past year.

What are the analyst and broker recommendations for Akoya Biosciences Inc?

There are no analysts currently covering Akoya Biosciences Inc.

When will Akoya Biosciences Inc next release its financial results?

It is not known when Akoya Biosciences Inc will next release financial results.

What is the Akoya Biosciences Inc dividend yield?

Akoya Biosciences Inc does not currently pay a dividend.

Does Akoya Biosciences Inc pay a dividend?

Akoya Biosciences Inc does not currently pay a dividend.

When does Akoya Biosciences Inc next pay dividends?

Akoya Biosciences Inc does not currently pay a dividend.

How do I buy Akoya Biosciences Inc shares?

To buy shares in Akoya Biosciences Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Akoya Biosciences Inc?

Shares in Akoya Biosciences Inc are currently trading at $17.89, giving the company a market capitalisation of £496.9m.

Where are Akoya Biosciences Inc shares listed? Where are Akoya Biosciences Inc shares listed?

Here are the trading details for Akoya Biosciences Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: AKYA
What kind of share is Akoya Biosciences Inc?

Based on an overall assessment of its quality, value and momentum, Akoya Biosciences Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Akoya Biosciences Inc share price forecast 2021?

We were not able to load any forecast data for Akoya Biosciences Inc.

How can I tell whether the Akoya Biosciences Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Akoya Biosciences Inc. Over the past six months, the relative strength of its shares against the market has been %. At the current price of $17.89, shares in Akoya Biosciences Inc are trading at -13.54% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Akoya Biosciences Inc PE Ratio?

We were not able to find PE ratio data for Akoya Biosciences Inc.

Who are the key directors of Akoya Biosciences Inc?

Akoya Biosciences Inc's management team is headed by:

Brian McKelligon - CEO
Terry Lo - PRE
Joe Driscoll - CFO
Peter Miller - VRD
Seth Benson - VOP
Who are the major shareholders of Akoya Biosciences Inc?

Here are the top five shareholders of Akoya Biosciences Inc based on the size of their shareholding:

Raffin (Thomas A) Individual Investor
Percentage owned: 43.91% (16.1m shares)
Telegraph Hill Partners Private Equity
Percentage owned: 42.74% (15.7m shares)
Piper Sandler Merchant Banking Fund II, L.P. Corporation
Percentage owned: 7.67% (2.81m shares)
Leland Stanford Junior University Corporation
Percentage owned: 6.12% (2.24m shares)
Winkler (Matthew) Individual Investor
Percentage owned: 2.13% (781k shares)
Similar to AKYA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.